Chemed Corp
Change company Symbol lookup
Select an option...
CHE Chemed Corp
ASTA WorldFlix Inc
$NQDM15LMCADN Nasdaq Developed Markets Telecommuni
BFZ BlackRock California Municipal Income Trust
CAR Avis Budget Group Inc
GIS General Mills Inc
VLN Valens Semiconductor Ltd
CIF MFS? Intermediate High Income Fund
LVOXW LiveVox Holdings Inc *W EXP 06/18/2026
SASR Sandy Spring Bancorp Inc
Go

Health Care : Health Care Providers & Services | Mid Cap Blend
Company profile

Chemed Corporation purchases, operates, and divests subsidiaries engaged in diverse business activities. The Company operates through two segments: the VITAS segment and Roto-Rooter segment. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. The Company's VITAS business is operated in the state of Florida. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. Its services are provided through a network of company-owned branches, independent contractors, and franchisees. The Company's subsidiaries include Chemed RT, Inc., Comfort Care Holdings Co., Comfort Care Holdings Co. and others.

Closing Price
$430.12
Day's Change
12.45 (2.98%)
Bid
--
Ask
--
B/A Size
--
Day's High
431.43
Day's Low
417.61
Volume
(Light)
Volume:
94,641

10-day average volume:
118,739
94,641

News that children could soon be eligible for Pfizer-BioNTech vaccine cheers parents, as Biden pushes vaccine requirements in Chicago

2:32 pm ET October 7, 2021 (MarketWatch)
Print

Ciara Linnane

'The president's message will be clear: Vaccination requirements work,' says White House

There was prospectively encouraging news for parents on Thursday when Pfizer and German partner BioNTech said they had submitted an application for emergency-use authorization of their COVID-19 vaccine in 5- to 11-year-old children.

The Food and Drug Administration will now review the safety and efficacy of the vaccine before deciding whether to authorize shots for that age group. The companies said late September that initial data from a late-stage trial of the vaccine in that demographic showed it was safe and effective and said data from a trial in children 6 months old to less than 2 years of age would come in the fourth quarter.

The news has come as a relief for some parents who have worried about the children's exposure to the virus now they are back in school settings.

U.S. new case numbers and hospitalizations have steadily declined in recent weeks, according to a New York Times tracker, although several hot spots remain, including Alaska, where some hospitals are rationing care. But the daily death toll remains above 1,800 -- an improvement from recent weeks in which it held above 2,000.

Experts and White House officials continue to urge unvaccinated people to get their shots, as those who have not been vaccinated account for the majority of cases and deaths. The U.S. has fully vaccinated abut 56% of its overall population, according to the CDC's vaccine tracker, a number that has remained nearly static for weeks.

Read: U.S. COVID-19 cases and hospitalizations continue to decline, but experts lament preventable deaths that have pushed toll above 700,000

Related: Are you allowed to ask your doctors and nurses if they're vaccinated? And do they have to answer?

President Joe Biden is set to visit Chicago on Thursday to push his message on vaccine requirements, a tool the White House has been using to help contain the spread. The administration will also release a report on how vaccine requirements are helping to drive up vaccine rates, put people back to work and bolster the economy, a White House official said in emailed comments.

See: Biden seeks to get 70% of world vaccinated within a year

"The president's message will be clear: Vaccination requirements work," said the official. "Vaccination requirements get more people vaccinated, helping to end the pandemic and strengthen the economy. That's why he's leading on implementing vaccination requirements for 100 million workers -- two-thirds of all workers in the U.S. And that's why we're seeing growing momentum for vaccination requirements across sectors and across the country."

The news comes after the White House said it would spend $1 billion on rapid, at-home tests to boost the nation's testing program.

In medical news, a study published in the New England Journal of Medicine found that women have higher protection against the virus following a second shot of the Pfizer-BioNTech (PFE)(BNTX) vaccine than men but that both genders see immunity wane within months of being fully inoculated.

The study involved more than 4,800 vaccinated healthcare workers in Israel and was conducted from December to July.

A separate study published in the journal Pediatrics Thursday found the sad news that more than 140,000 children in the U.S. have lost to COVID a parent or a grandparent who was a primary caregiver, the majority of whom are children of color. The study covered losses from April 1, 2020, through this June. Since then, the authors estimate, the number has grown to 175,000.

"The risk of such loss was 1.1 to 4.5 times higher among children of racial and ethnic minorities, compared to non-Hispanic White children," the authors wrote. "The highest burden of COVID-19-associated death of parents and caregiversoccurred in Southern border states for Hispanic children, Southeastern states for Black children, and in states with tribal areas for American Indian/Alaska Native populations."

See also:'Do I just suffer and hope things get better?' COVID-19 long haulers face fears of reinfection, unvaccinated Americans and medical bills

Elsewhere, a number of Nordic countries, including Denmark, Finland and Sweden, are limiting the use of the Moderna vaccine to certain age groups over concerns about rare cases of myocarditis and pericarditis in younger people who have received the vaccine. The news sent Moderna shares (MRNA) lower early Thursday before an intraday rebound.

See now:Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna's revenue next year

Australia's biggest city, Sydney, will emerge from a 106-day lockdown next Monday, after officials confirmed that vaccination goals have been met, AFP reported Stay-at-home orders will be lifted for the Harbour City's 5 million--plus people now that 70% of state residents over 16 have been double jabbed.

The World Health Organization has started to ship medical products to North Korea, the Washington Post reported, in a sign that the secretive country is looking for outside help. North Korea has long denied having any COVID cases, despite a long and highly porous border with China.

The first batch of AstraZeneca (AZN.LN) vaccine has reached the Antarctic, the BBC reported, where it will be used to immunize 23 staff members at the British Rothera research station running through the polar winter.

Latest tallies

The global tally for the coronavirus-borne illness climbed above 236.7 million on Thursday, while the death toll rose above 4.83 million, according to data aggregated by Johns Hopkins University.

The U.S. continues to lead the world with a total of 44 million cases and 708,434 deaths.

India is second by cases after the U.S. at 33.9 million and has suffered 449,856 deaths. Brazil has the second highest death toll at 599,359 and 21.5 million cases.

In Europe, Russia has reported the most fatalities at 209,752, followed by the U.K. at 137,816.

China, where the virus was first discovered late in 2019, has had 108,662 confirmed cases and 4,809 deaths, according to its official numbers, which are widely held to be massively underreported.

-Ciara Linnane

	

(END) Dow Jones Newswires

October 07, 2021 14:32 ET (18:32 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.